Want to join the conversation?
$PSA 1Q15 10-Q: 1Q15-end cash and cash equivalents increased $51.69MM to $152.80MM vs $101.11MM in 1Q14. As of March 31, 2015, capital resources totaled approx. $848MM consisting of $153MM in cash, approx. $485MM of available borrowing capacity on the line of credit, and $210MM of expected retained operating cash flow for the next 12 months.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.